SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Angiology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Seybold, K.
Right arrow Articles by Locher, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seybold, K.
Right arrow Articles by Locher, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Nuclear Scans
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Immunoscintigraphy of Infections Using 123I and 99mTc-Labeled Monoclonal Antibodies. Advanced Experiences in 230 Patients

K. Seybold, M.D., F.A.C.A.

Department of Nuclearmedicine, Cantonal Hospital, Aarau, Switzerland

L.D. Frey, M.D.

Department of Nuclearmedicine, Cantonal Hospital, Aarau, Switzerland

J. Locher, M.D.

Department of Nuclearmedicine, Cantonal Hospital, Aarau, Switzerland

Advanced experiences show an extremely high diagnostic potential in im munoscintigraphy of infections using monoclonal antigranulocytes antibodies (Mab). There was no hampering of the biological properties of the granulocytes after in vivo labeling with 123I or 99mTc-tagged Mabs. There were mostly identi cal findings and an equal functional behavior of the granulocytes observed with the use of different agents. Diagnosis of infections was made mostly within four to six hours p.i. 99mTc labeling is more advantageous than 123 I because of better image quality, constant availability, and lower costs. 123I Mab 47 seems to be recommended in some cases of chronic osteomyelitis and spondylitis. No rele vant antigenicity was observed in follow-up studies of testing HAMA serum levels. Only a few short-time reactions were seen after repeated administration of 99mTc Mab. There were no side effects and no allergic or adverse reactions.

Despite these methodical advantages of the immunoscintigraphic detection of infectious and inflammatory lesions, this method should be further restricted to severe cases or patients in whom other methods would not be practicable or have failed. HAMA controls are continued in all our patients undergoing im munoscintigraphy.

Angiology, Vol. 43, No. 2, 85-90 (1992)
DOI: 10.1177/000331979204300201


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
RadiologyHome page
E. E. Pakos, H. D. Koumoulis, A. D. Fotopoulos, and J. P. A. Ioannidis
Osteomyelitis: Antigranulocyte Scintigraphy with 99mTc Radiolabeled Monoclonal Antibodies for Diagnosis Meta-Analysis
Radiology, December 1, 2007; 245(3): 732 - 741.
[Abstract] [Full Text] [PDF]



Advertisement